Abstract: Bridged cyclometalated carbene complexes, a process for preparing the bridged cyclometalated carbene complexes, the use of the bridged cyclometalated carbene complexes in organic light-emitting diodes, organic light-emitting diodes comprising at least one inventive bridged cyclometalated carbene complex, a light-emitting layer comprising at least one inventive bridged cyclometalated carbene complex, organic light-emitting diodes comprising at least one inventive light-emitting layer and devices which comprise at least one inventive organic light-emitting diode.

Abstract: A process for converting a compound C1 of the formula I in a mer isomer form into an isomeric compound C2 of the formula I in a fac isomer form.

Abstract: The present invention relates to an organic light-emitting diode comprising an anode An and a cathode Ka and a light-emitting layer E which is arranged between the anode An and the cathode Ka and comprises at least one carbene complex and if appropriate at least one further layer, where the light-emitting layer E and/or the at least one further layer comprises at least one compound selected from disilylcarbazoles, disilyldibenzofurans, disilyldibenzothiophenes, disilyldibenzophospholes, disilyldibenzothiophene S-oxides and disilyldibenzothiophene S,S-dioxides, to a light-emitting layer comprising at least one of the aforementioned compounds and at least one carbene complex, to the use of the aforementioned compounds as matrix material, hole/exciton blocker material, electron/exciton blocker material, hole injection material, electron injection material, hole conductor material and/or electron conductor material, and to a device selected from the group consisting of stationary visual display units, mobile visu

Abstract: The present invention relates to the use of (hetero)aryl-substituted acridine derivatives as matrix materials in a light-emitting layer of organic light-emitting diodes (OLEDs) and/or in a blocking layer for electrons in organic light-emitting diodes. The present invention further relates to a light-emitting layer which comprises at least one emitter material and at least one matrix material, wherein the matrix material used is at least one (hetero)aryl-substituted acridine derivative, and to an organic light-emitting diode which comprises at least one inventive light-emitting layer, to an organic light-emitting diode which comprises at least one acridine derivative of the formula (I) in a blocking layer for electrons, and to a device selected from stationary and mobile visual display units and illumination units which comprise at least one inventive organic light-emitting diode.

Abstract: Bridged cyclometalated carbene complexes, a process for preparing the bridged cyclometalated carbene complexes, the use of the bridged cyclometalated carbene complexes in organic light-emitting diodes, organic light-emitting diodes comprising at least one inventive bridged cyclometalated carbene complex, a light-emitting layer comprising at least one inventive bridged cyclometalated carbene complex, organic light-emitting diodes comprising at least one inventive light-emitting layer and devices which comprise at least one inventive organic light-emitting diode.

Abstract: Silanes comprising phenothiazine S-oxide or phenothiazine S,S-dioxide groups, organic light-emitting diodes comprising the inventive silanes, a light-emitting layer comprising at least one inventive silane and at least one triplet emitter, a process for preparing the inventive silanes and the use of the inventive silanes in organic light-emitting diodes, preferably as matrix materials and/or blocker materials for triplet emitters.

Abstract: The present invention relates to an organic light-emitting diode which has a light-emitting layer C which comprises at least one hole-conducting material CA and at least one phosphorescence emitter CB, to mixtures comprising at least one carbene complex in combination with at least one hole-conducting material or in combination with at least one phosphorescence emitter, and to the use of mixtures comprising at least one hole-conducting material and at least one phosphorescence emitter as a light-emitting layer in OLEDs for prolonging the lifetime of the light-emitting layer.

Abstract: The present invention relates to heteroleptic carbene complexes comprising at least two different carbene ligands, to a process for preparing the heteroleptic carbene complexes, to the use of the heteroleptic carbene complexes in organic light-emitting diodes, to organic light-emitting diodes comprising at least one inventive heteroleptic carbene complex, to a light-emitting layer comprising at least one inventive heteroleptic carbene complex, to organic light-emitting diodes comprising at least one inventive light-emitting layer, and to devices which comprise at least one inventive organic light-emitting diode.

Abstract: The present invention relates to heteroleptic carbene complexes comprising both carbene ligands and heterocyclic noncarbene ligands, to a process for preparing the heteroleptic carbene complexes, to the use of the heteroleptic carbene complexes in organic light-emitting diodes, to organic light-emitting diodes comprising at least one inventive heteroleptic carbene complex, to a light-emitting layer comprising at least one inventive heteroleptic carbene complex, to organic light-emitting diodes comprising at least one inventive light-emitting layer, and to devices which comprise at least one inventive organic light-emitting diode.

Abstract: Process for preparing cyclometallated transition metal-carbene complexes comprising at least one carbene ligand, which comprises reacting a ligand precursor with a base, an auxiliary reagent and a metal complex comprising at least one metal M1 (route A) or reacting the ligand precursor with a basic auxiliary reagent and a metal complex comprising at least one metal M1 (route B). The present invention further relates to the use of an auxiliary reagent selected from among salts comprising at least one metal selected from the group consisting of Ag, Hg, Sb, Mg, B and Al together with a base in a process for preparing cyclometallated metal complexes.

Abstract: The present invention relates to a process for converting an isomerically pure compound C1 of the formula I or a mixture M1 comprising C1 into an isomeric compound C2 of the formula I which is different from C1 or a mixture M2 comprising C2, where the variables have the following meanings: n is 2 or 3; M is Pd or Pt, in each case in the formal oxidation state +II, when n is 2; and is Ru, Os, Co, Rh or Ir, in each case in the formal oxidation state +III, when n is 3; Do is a donor atom selected from the group consisting of N, O, S and P; r is 1 when Do is N or P, and is 0 when Do is O or S; Y1, Y2 are each, independently of one another, hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, alkyloxy, aryloxy, alkylthio, arylthio, alkylcarbonyl, arylcarbonyl, carboxyl, alkyloxycarbonyl, aryloxycarbonyl, hydroxysulfonyl, alkyloxysulfonyl, aryloxysulfonyl, halogen, CN, CHO, NO2 or NO, or Y1 and Y2 together with the carbon atom to which they are bound form a six-membered aromatic ring which may comprise one

Abstract: The invention on hand refers to diseases associated with abnormal protein structures, including Alzheimer's disease, Creutzfeldt-Jakob's disease, BSE and other prion-associated diseases. It is the task of the invention on hand to provide new active agents preventing the formation of amyloid plaques and to dissolve existing plaques, such agents being convenient for therapy, diagnosis and prophylaxis of diseases that are associated with abnormal protein structures. This task is performed in terms of the current invention by heterocyclic or aromatic agents with a rigid structure and a donor-acceptor-donor pattern (DAD), the latter being formed by donors and acceptors of hydrogen bridge linkages which comply with the ?-sheet structure of the peptide or protein and thus fit as binding partners. The heterocyclic or aromatic agents are available at least as dimers. They recognise peptides and proteins with a ?-sheet structure, form stable complexes with them and inhibit their aggregation to ?-amyloid plaques.